Severe myopericarditis following the third dose of an mRNA COVID-19 vaccine: utility of a multimodal treatment approach.

Category Primary study
JournalBMJ case reports
Year 2022
We report a rare case of severe myopericarditis in a healthy man in his 20s after the third dose of an mRNA COVID-19 vaccine. His symptoms and troponinemia resolved with a beta-blocker in addition to standard anti-inflammatory therapy, highlighting the utility of multimodal therapy.
Epistemonikos ID: 4f45019f168cde39bd32a8cbbedd1a7d156020e9
First added on: Jun 30, 2022